Unusual effects of aspirin on ticlopidine induced thrombolysis

Gryglewski, R J; Uracz, W; Święs, J
October 2000
Thorax;Oct2000 Supp, Vol. 55, pS17
Academic Journal
No abstract available.


Related Articles

  • Ticlopidine vs. aspirin in the prevention of stroke.  // American Family Physician;7/1/1994, Vol. 50 Issue 1, p178 

    Reviews the efficacy of ticlopidine versus aspirin in the prevention of stroke. Antiplatelet properties of ticlopidine; Other physiological effects; Establishment of the efficacy of ticlopidine; Aspirin's reducing effect on risks of ischemic stroke; Side effects.

  • Effects of Ticlopidine or Ticlopidine Plus Aspirin on Platelet Aggregation and ATP Release in Normal Volunteers: Why Aspirin Improves Ticlopidine Antiplatelet Activity. Altman, Raul; Scazziota, Alejandra; Rouvier, Jorge; Gonzalez, Claudio // Clinical & Applied Thrombosis/Hemostasis;Oct1999, Vol. 5 Issue 4, p243 

    Aspirin and ticlopidine are used to prevent arterial thrombosis. In some clinical settings ticlopidine is administered with aspirin for improving antithrombotic effect. We administered aspirin (100 mg/day), ticlopidine (500mg/day), or ticlopidine and aspirin for 7 days to healthy volunteers....

  • Differential Impacts of CYP2C19 Gene Polymorphisms on the Antiplatelet Effects of Clopidogrel and Ticlopidine. Maeda, A.; Ando, H.; Asai, T.; Ishiguro, H.; Umemoto, N.; Ohta, M.; Morishima, M.; Sumida, A.; Kobayashi, T.; Hosohata, K.; Ushijima, K.; Fujimura, A. // Clinical Pharmacology & Therapeutics;Feb2011, Vol. 89 Issue 2, p229 

    We examined the influence of CYP2C19 polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. The platelet aggregation induced by 20 µmol/l adenosine diphosphate (ADP) and CYP2C19 single-nucleotide polymorphisms (*2 and *3) was determined in patients with coronary artery...

  • Thrombolytics: drug interactions of clinical significance. Harder, S.; Klinkhardt, U. // Drug Safety;Nov2000, Vol. 23 Issue 5, p391 

    Thrombolytic agents activate plasminogen and induce a systemic fibrinolytic and anticoagulant state. Interaction of fibrinolysis with coagulation and platelet aggregation might be important for synergistic interactions with other antiplatelet or anticoagulant drugs. Thrombolytic agents are most...

  • Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)? Olson, John; Huntington, Jane // Journal of Family Practice;Jul2001, Vol. 50 Issue 7, p623 

    The article discusses research being done on the comparison of ticlopidine with aspirin after myocardial infarction (MI). It references to a study by D. Scrutinio et al published in the 2001 issue of the "Journal of American College Cardiology." The study found that ticlopidine is as effective...

  • Prophylactic drug therapy in cerebrovascular disease. Unwin, D. Hal; Greenlee Jr., Ralph G. // American Family Physician;7/1/1993, Vol. 48 Issue 1, p85 

    Discusses the prophylactic drug therapy in cerebrovascular disease. Prophylaxis regimens and outcomes of aspirin; Dipyridamole and sulfinpyrazone; Efficacy and adverse effects of ticlopidine; Role of warfarin in ischemic cerebrovascular disease.

  • New Drug Can Avert Strokes.  // USA Today Magazine;Feb89, Vol. 117 Issue 2525, p12 

    Discusses the results of the clinical trials of Ticlopidine, an anti-platelet agent that reduces platelet aggregation in the blood. Comparison of the drug with stroke-prevention drug, aspirin; Side effects.

  • The Effect of Antiplatelet Drugs, Heparin, and Preanalytical Variables on Platelet Function Detected by the Platelet Function Analyzer (PFA-100®). Kottke-Marchant, Kandice; Powers, James B.; Brooks, Linda; Kundu, Sourav; Christie, Douglas J. // Clinical & Applied Thrombosis/Hemostasis;Apr1999, Vol. 5 Issue 2, p122 

    The platelet function analyzer (PFA)-100® is a newly developed instrument that provides a rapid, in vitro, quantitative measurement of platelet adhesion and aggregation in whole blood flowing through a small aperture under high shear conditions. Thirty patients undergoing percutaneous...

  • Preventing TIAs: Ticlopidine is more effective than aspirin.  // Geriatrics;Mar94, Vol. 49 Issue 3, p64 

    Presents an abstract on the article `Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events,' by A.Bellevance. Comparison between ticlopidine and aspirin recipients; Reduction of risk of reversible ischemic events.

  • Ticlopidine prevents TIAs better than aspirin.  // Modern Medicine;Mar94, Vol. 62 Issue 3, p61 

    Presents an abstract of the article entitled `Efficacy of Ticlopidine and Aspirin for Prevention of Reversible Cerebrovascular Ischemic Events: The Ticlopidine Aspirin Stroke Study,' by A. Bellevance published in the October 1993 issue of the journal `Stroke.'


Read the Article


Sign out of this library

Other Topics